Loading...

Treatment discontinuation and re-initiation of anti-PD-(L)1 agents in metastatic cancers

INTRODUCTION: Immune checkpoint inhibitors (ICIs) are approved in multiple indications for cancer care. Most of the clinical trials have not questioned shorter than until disease progression approaches. In this study, we present results from a cohort of multiple advanced cancers treated with restric...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Cancer Res Clin Oncol
Main Authors: Tikkanen, Antti, Iivanainen, Sanna, Koivunen, Jussi P.
Format: Artigo
Sprog:Inglês
Udgivet: Springer Berlin Heidelberg 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7324422/
https://ncbi.nlm.nih.gov/pubmed/32306129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-020-03217-7
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!